Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
Justus G Garweg1,21Swiss Eye Institute, Rotkreuz, and Berner Augenklinik Am Lindenhofspital, Bern, Switzerland; 2Department of Ophthalmology, Inselspital, University of Bern, Bern, SwitzerlandPurpose: To review published evidence for a treatment interval extension to ≥12-weeks in neovascular...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/261e998235554db1a3605447656a0880 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|